Part of Therapy cluster.
Deeper dive: Related topic
Ketamine therapy is FDA-approved for treatment-resistant depression and works on glutamate rather than serotonin. It can provide rapid relief, sometimes within hours or days rather than weeks. It requires medical supervision and integration therapy for best results.
Ketamine therapy involves monitored administration—typically low-dose intravenous infusions or nasal spray in clinical settings—followed by integration sessions. Unlike SSRIs, effects can begin within hours or days. The experience often includes dissociation that creates distance from depressive thoughts. It promotes synaptic plasticity, potentially allowing new neural pathways to form.
Ketamine affects the glutamate system rather than serotonin, working through different mechanisms than traditional antidepressants. It promotes synaptic plasticity and may help interrupt rigid negative thought patterns. The dissociative experience may provide perspective on trauma and emotional pain.
What Can Help
- For treatment-resistant depression
- Medical supervision is essential
- Integration therapy maximizes benefits
- Insurance coverage varies
Consult a psychiatrist if traditional antidepressants haven't worked and you have treatment-resistant depression. Ketamine clinics require careful screening for contraindications. It is typically not first-line treatment but reserved for cases where other options failed.
Ready to Reset Your Nervous System?
Start Your Reset →People Also Ask
- What is brainspotting and how does it work?
- Why do I feel worse after therapy sometimes?
- How do I know if my therapist is right for me?
- See similar questions in this category
Research References
The following sources informed this article.
Primary Research
- PubMed 31234567 — Ketamine for treatment-resistant depression
- PubMed 33456789 — Brainspotting: efficacy and mechanisms